Drug Discovery World

DECEMBER 13, 2022

Optibrium, a developer of software and artificial intelligence (AI) solutions for drug discovery, recently announced the promotion of Dr Tamsin Mansley to President of its new subsidiary to lead its US-based team and business operations. TM: AI plays a vital role in the drug discovery process by enabling chemists to do their best work.

Science 130

Science Computational Chemistry Drugs Production 130

Sygnature Discovery

MAY 9, 2022

Sygnature are thrilled to announce that we have embarked on a 3-year collaboration agreement with Iktos , an innovative technology company specialising in Artificial Intelligence (AI) for new drug design.

Computational Chemistry 52

Computational Chemistry Pharmaceutical Companies Science Pharmaceuticals 52

Practical Cheminformatics

DECEMBER 7, 2023

A recent editorial by Dean Brown in J Med Chem and follow-up posts by Keith Hornberger and Derek Lowe prompted me to think about how we train computational chemists and cheminformaticians for careers in drug discovery. Like medicinal chemists, most computational chemists learn on the job from more experienced colleagues.

Computational Chemistry 90

Computational Chemistry Pharmacokinetics Pharmaceutical Companies Drugs 90

Sygnature Discovery

JULY 31, 2023

Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. Previous acquisitions made were Peak Proteins in April 2022 and SB Drug Discovery in January 2023. Marc Lebel, Pharm.

Computational Chemistry 52

Computational Chemistry Science Pharmaceutical Companies Clinical Trials 52

The Pharma Data

DECEMBER 13, 2020

Since its establishment, Viva Biotech has been providing comprehensive new drug R&D services to nearly 500 world’s top pharmaceutical and biotech companies based on Viva’s excellence in structure-based drug discovery.

Small Molecule 40

Small Molecule Computational Chemistry Pharmaceuticals Production 40

DrugBank

JUNE 27, 2024

Drug repurposing is an approach that, while not new, has become popular in the last decade.   One of the most exciting prospects of drug repurposing is its potential to tackle "undruggable" targets—proteins or molecules that traditional drugs can't easily bind to.

Drugs 73

Drugs Pharma Companies Computational Chemistry Clinical Trials 73

The Pharma Data

NOVEMBER 15, 2020

” Arthur Oubrie, Chief Scientific Officer of Lead Pharma, added: “This is the second project we partner with one of the largest pharmaceutical companies under our Discover, Design and Deliver platform. . Lead Pharma may receive payments of up to €260 million plus royalties on sales. OSS, Netherlands , Nov.

Small Molecule 52

Small Molecule Licensing Licensing Disease 52